The global Lancets market size is predicted to grow from US$ 1706 million in 2025 to US$ 2260 million in 2031; it is expected to grow at a CAGR of 4.8% from 2025 to 2031.
Lancets are a pricking needle used to obtain drops of blood for testing. Lancets are being increasingly used by patients affected by cardiovascular and endocrine-related complications. Lancets are designed to only be used once, and then disposed of in a safe way. These devices are being used for cholesterol and glucose tests, heelstick screening tests or phenylketonuria (PKU) tests in newborns, as well as for severely burned or scarred emergency patients, extremely obese patients and thrombotic-tendency patients.
Market Drivers:
Growing prevalence of chronic diseases: The rise in chronic conditions like diabetes, which require regular blood glucose monitoring, is a significant driver for lancet demand. As the number of diabetes patients increases globally, the need for lancets continues to grow.
Technological advancements in lancets: Innovations such as ultra-thin needles, painless lancet designs, and easy-to-use lancet devices improve user experience, making blood sampling more comfortable and encouraging more frequent use.
Increase in home-based healthcare: The trend toward home healthcare and self-monitoring for various conditions, especially diabetes, has driven the use of lancets. This allows patients to monitor their health in a more convenient and cost-effective way, increasing the market for these devices.
Aging population: The growing elderly population is more prone to chronic diseases like diabetes, requiring regular blood monitoring. This demographic shift is a major factor pushing the demand for lancets and other monitoring devices.
Rising awareness of preventive healthcare: Increasing awareness of the importance of regular health monitoring, especially for managing conditions like diabetes, has led to higher adoption of lancets for routine blood tests and glucose monitoring.
Market Challenges:
Competition from alternative technologies: Non-invasive blood glucose monitoring methods (such as continuous glucose monitors or sensor-based systems) are gaining traction, potentially reducing the reliance on traditional lancets for blood sampling.
High recurring costs for patients: Lancets are single-use devices, and the recurring cost for people who need frequent testing can become a financial burden, particularly in low-income regions or for uninsured patients, limiting market growth.
Infection risks: Improper or repeated use of lancets can lead to infections, particularly if they are not disposed of properly or if reused by mistake, which poses a health risk and deters their use.
Environmental concerns: Lancets contribute to medical waste, as they are disposable devices, raising concerns about environmental impact. This could lead to regulatory pressures or a shift toward more sustainable alternatives.
Regulatory compliance and approval hurdles: The lancet market is subject to stringent regulations and approval processes from health authorities. This can slow down the introduction of new products and innovations, delaying their availability in the market.
The classification of Lancets includes Ordinary Lancets and Safety Lancets. In 2023, Ordinary Lancets accounted for a share of 61.81% in the global Lancets market. With several hospitals and healthcare facilities converting to safety lancets, this market share is poised for declined. Americas is the largest consumption place, with a consumption market share nearly 40 % in 2022. Following Americas, Europe is the second largest consumption place with the consumption market share of 30 %.
The 鈥淟ancets Industry Forecast鈥� looks at past sales and reviews total world Lancets sales in 2024, providing a comprehensive analysis by region and market sector of projected Lancets sales for 2025 through 2031. With Lancets sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Lancets industry.
This Insight Report provides a comprehensive analysis of the global Lancets landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Lancets portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Lancets market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Lancets and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Lancets.
This report presents a comprehensive overview, market shares, and growth opportunities of Lancets market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Safety Lancets
Ordinary Lancets
Segmentation by Application:
Children's Fingertip Blood Tests
Glucose Tests
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Roche
Lifescan
BD
Ascensia
Abbott
B. Braun
ARKRAY
Terumo
I-SENS
Nipro
Cardinal Health
ICU Medical
Sarstedt
Sinocare
Yicheng
Yuwell
Greiner Bio One
Guangzhou iCare Medical
Shandong Lianfa
Tianjin Huahong
Owen Mumford
HemoCue
HTL-STREFA
UltiMed
SteriLance Medical
Key Questions Addressed in this Report
What is the 10-year outlook for the global Lancets market?
What factors are driving Lancets market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Lancets market opportunities vary by end market size?
How does Lancets break out by Type, by Application?
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Lancets Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Lancets by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Lancets by Country/Region, 2020, 2024 & 2031
2.2 Lancets Segment by Type
2.2.1 Safety Lancets
2.2.2 Ordinary Lancets
2.3 Lancets Sales by Type
2.3.1 Global Lancets Sales Market Share by Type (2020-2025)
2.3.2 Global Lancets Revenue and Market Share by Type (2020-2025)
2.3.3 Global Lancets Sale Price by Type (2020-2025)
2.4 Lancets Segment by Application
2.4.1 Children's Fingertip Blood Tests
2.4.2 Glucose Tests
2.4.3 Others
2.5 Lancets Sales by Application
2.5.1 Global Lancets Sale Market Share by Application (2020-2025)
2.5.2 Global Lancets Revenue and Market Share by Application (2020-2025)
2.5.3 Global Lancets Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Lancets Breakdown Data by Company
3.1.1 Global Lancets Annual Sales by Company (2020-2025)
3.1.2 Global Lancets Sales Market Share by Company (2020-2025)
3.2 Global Lancets Annual Revenue by Company (2020-2025)
3.2.1 Global Lancets Revenue by Company (2020-2025)
3.2.2 Global Lancets Revenue Market Share by Company (2020-2025)
3.3 Global Lancets Sale Price by Company
3.4 Key Manufacturers Lancets Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Lancets Product Location Distribution
3.4.2 Players Lancets Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Lancets by Geographic Region
4.1 World Historic Lancets Market Size by Geographic Region (2020-2025)
4.1.1 Global Lancets Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Lancets Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Lancets Market Size by Country/Region (2020-2025)
4.2.1 Global Lancets Annual Sales by Country/Region (2020-2025)
4.2.2 Global Lancets Annual Revenue by Country/Region (2020-2025)
4.3 Americas Lancets Sales Growth
4.4 APAC Lancets Sales Growth
4.5 Europe Lancets Sales Growth
4.6 Middle East & Africa Lancets Sales Growth
5 Americas
5.1 Americas Lancets Sales by Country
5.1.1 Americas Lancets Sales by Country (2020-2025)
5.1.2 Americas Lancets Revenue by Country (2020-2025)
5.2 Americas Lancets Sales by Type (2020-2025)
5.3 Americas Lancets Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Lancets Sales by Region
6.1.1 APAC Lancets Sales by Region (2020-2025)
6.1.2 APAC Lancets Revenue by Region (2020-2025)
6.2 APAC Lancets Sales by Type (2020-2025)
6.3 APAC Lancets Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Lancets by Country
7.1.1 Europe Lancets Sales by Country (2020-2025)
7.1.2 Europe Lancets Revenue by Country (2020-2025)
7.2 Europe Lancets Sales by Type (2020-2025)
7.3 Europe Lancets Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Lancets by Country
8.1.1 Middle East & Africa Lancets Sales by Country (2020-2025)
8.1.2 Middle East & Africa Lancets Revenue by Country (2020-2025)
8.2 Middle East & Africa Lancets Sales by Type (2020-2025)
8.3 Middle East & Africa Lancets Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Lancets
10.3 Manufacturing Process Analysis of Lancets
10.4 Industry Chain Structure of Lancets
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Lancets Distributors
11.3 Lancets Customer
12 World Forecast Review for Lancets by Geographic Region
12.1 Global Lancets Market Size Forecast by Region
12.1.1 Global Lancets Forecast by Region (2026-2031)
12.1.2 Global Lancets Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Lancets Forecast by Type (2026-2031)
12.7 Global Lancets Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Roche
13.1.1 Roche Company Information
13.1.2 Roche Lancets Product Portfolios and Specifications
13.1.3 Roche Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Roche Main Business Overview
13.1.5 Roche Latest Developments
13.2 Lifescan
13.2.1 Lifescan Company Information
13.2.2 Lifescan Lancets Product Portfolios and Specifications
13.2.3 Lifescan Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Lifescan Main Business Overview
13.2.5 Lifescan Latest Developments
13.3 BD
13.3.1 BD Company Information
13.3.2 BD Lancets Product Portfolios and Specifications
13.3.3 BD Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 BD Main Business Overview
13.3.5 BD Latest Developments
13.4 Ascensia
13.4.1 Ascensia Company Information
13.4.2 Ascensia Lancets Product Portfolios and Specifications
13.4.3 Ascensia Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Ascensia Main Business Overview
13.4.5 Ascensia Latest Developments
13.5 Abbott
13.5.1 Abbott Company Information
13.5.2 Abbott Lancets Product Portfolios and Specifications
13.5.3 Abbott Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Abbott Main Business Overview
13.5.5 Abbott Latest Developments
13.6 B. Braun
13.6.1 B. Braun Company Information
13.6.2 B. Braun Lancets Product Portfolios and Specifications
13.6.3 B. Braun Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 B. Braun Main Business Overview
13.6.5 B. Braun Latest Developments
13.7 ARKRAY
13.7.1 ARKRAY Company Information
13.7.2 ARKRAY Lancets Product Portfolios and Specifications
13.7.3 ARKRAY Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 ARKRAY Main Business Overview
13.7.5 ARKRAY Latest Developments
13.8 Terumo
13.8.1 Terumo Company Information
13.8.2 Terumo Lancets Product Portfolios and Specifications
13.8.3 Terumo Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Terumo Main Business Overview
13.8.5 Terumo Latest Developments
13.9 I-SENS
13.9.1 I-SENS Company Information
13.9.2 I-SENS Lancets Product Portfolios and Specifications
13.9.3 I-SENS Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 I-SENS Main Business Overview
13.9.5 I-SENS Latest Developments
13.10 Nipro
13.10.1 Nipro Company Information
13.10.2 Nipro Lancets Product Portfolios and Specifications
13.10.3 Nipro Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Nipro Main Business Overview
13.10.5 Nipro Latest Developments
13.11 Cardinal Health
13.11.1 Cardinal Health Company Information
13.11.2 Cardinal Health Lancets Product Portfolios and Specifications
13.11.3 Cardinal Health Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Cardinal Health Main Business Overview
13.11.5 Cardinal Health Latest Developments
13.12 ICU Medical
13.12.1 ICU Medical Company Information
13.12.2 ICU Medical Lancets Product Portfolios and Specifications
13.12.3 ICU Medical Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 ICU Medical Main Business Overview
13.12.5 ICU Medical Latest Developments
13.13 Sarstedt
13.13.1 Sarstedt Company Information
13.13.2 Sarstedt Lancets Product Portfolios and Specifications
13.13.3 Sarstedt Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Sarstedt Main Business Overview
13.13.5 Sarstedt Latest Developments
13.14 Sinocare
13.14.1 Sinocare Company Information
13.14.2 Sinocare Lancets Product Portfolios and Specifications
13.14.3 Sinocare Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Sinocare Main Business Overview
13.14.5 Sinocare Latest Developments
13.15 Yicheng
13.15.1 Yicheng Company Information
13.15.2 Yicheng Lancets Product Portfolios and Specifications
13.15.3 Yicheng Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Yicheng Main Business Overview
13.15.5 Yicheng Latest Developments
13.16 Yuwell
13.16.1 Yuwell Company Information
13.16.2 Yuwell Lancets Product Portfolios and Specifications
13.16.3 Yuwell Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
13.16.4 Yuwell Main Business Overview
13.16.5 Yuwell Latest Developments
13.17 Greiner Bio One
13.17.1 Greiner Bio One Company Information
13.17.2 Greiner Bio One Lancets Product Portfolios and Specifications
13.17.3 Greiner Bio One Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
13.17.4 Greiner Bio One Main Business Overview
13.17.5 Greiner Bio One Latest Developments
13.18 Guangzhou iCare Medical
13.18.1 Guangzhou iCare Medical Company Information
13.18.2 Guangzhou iCare Medical Lancets Product Portfolios and Specifications
13.18.3 Guangzhou iCare Medical Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
13.18.4 Guangzhou iCare Medical Main Business Overview
13.18.5 Guangzhou iCare Medical Latest Developments
13.19 Shandong Lianfa
13.19.1 Shandong Lianfa Company Information
13.19.2 Shandong Lianfa Lancets Product Portfolios and Specifications
13.19.3 Shandong Lianfa Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
13.19.4 Shandong Lianfa Main Business Overview
13.19.5 Shandong Lianfa Latest Developments
13.20 Tianjin Huahong
13.20.1 Tianjin Huahong Company Information
13.20.2 Tianjin Huahong Lancets Product Portfolios and Specifications
13.20.3 Tianjin Huahong Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
13.20.4 Tianjin Huahong Main Business Overview
13.20.5 Tianjin Huahong Latest Developments
13.21 Owen Mumford
13.21.1 Owen Mumford Company Information
13.21.2 Owen Mumford Lancets Product Portfolios and Specifications
13.21.3 Owen Mumford Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
13.21.4 Owen Mumford Main Business Overview
13.21.5 Owen Mumford Latest Developments
13.22 HemoCue
13.22.1 HemoCue Company Information
13.22.2 HemoCue Lancets Product Portfolios and Specifications
13.22.3 HemoCue Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
13.22.4 HemoCue Main Business Overview
13.22.5 HemoCue Latest Developments
13.23 HTL-STREFA
13.23.1 HTL-STREFA Company Information
13.23.2 HTL-STREFA Lancets Product Portfolios and Specifications
13.23.3 HTL-STREFA Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
13.23.4 HTL-STREFA Main Business Overview
13.23.5 HTL-STREFA Latest Developments
13.24 UltiMed
13.24.1 UltiMed Company Information
13.24.2 UltiMed Lancets Product Portfolios and Specifications
13.24.3 UltiMed Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
13.24.4 UltiMed Main Business Overview
13.24.5 UltiMed Latest Developments
13.25 SteriLance Medical
13.25.1 SteriLance Medical Company Information
13.25.2 SteriLance Medical Lancets Product Portfolios and Specifications
13.25.3 SteriLance Medical Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
13.25.4 SteriLance Medical Main Business Overview
13.25.5 SteriLance Medical Latest Developments
14 Research Findings and Conclusion
听
听
*If Applicable.
